Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06362941 · ClinicalTrials.gov registry record · NA
Evaluation of an Oral Hair Supplement to Improve Hair Strength and Support Growth in Women and Men
A NA study, sponsored by Nutraceutical Wellness.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
NCT06362941: Completed NA study, sponsored by Nutraceutical Wellness.
NCT06362941 is a NA study that has completed, run by Nutraceutical Wellness. The registered enrollment target is 250 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06362941, a NA study, has completed, sponsored by Nutraceutical Wellness.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
Study Summary
A single-center, open-label, prospective study to demonstrate the efficacy of an oral supplement to improve the strength and support the growth of thinning hair in men and women with self-perceived hair thinning.
Primary Outcome
The ability of an oral supplement to improve hair shaft strength as evidenced by change in hair shaft diameter from baseline at Day 180 in new scalp hair growth as viewed by the study dermatologist under a light microscope in men and women with self-perceived thinning hair.
Interventions
- DIETARY_SUPPLEMENT Nutrafol Women's Hair Growth Supplemnt
- DIETARY_SUPPLEMENT Nutrafol Women's Balance Hair Growth Supplement
- DIETARY_SUPPLEMENT Nutrafol Women's Vegan Hair Growth Supplement
- DIETARY_SUPPLEMENT Nutrafol Women's Postpartum Hair Growth Supplement
- DIETARY_SUPPLEMENT Nutrafol Men's Hair Growth Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2024-05-20 |
| Est. Completion | 2025-02-18 |
| Phase | NA |
What the finished NCT06362941 record still lists
NCT06362941 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 5 interventions - of which Nutrafol Women's Hair Growth Supplemnt is the first listed.
NCT06362941 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06362941 about?
NCT06362941 is a clinical study titled "Evaluation of an Oral Hair Supplement to Improve Hair Strength and Support Growth in Women and Men". A single-center, open-label, prospective study to demonstrate the efficacy of an oral supplement to improve the strength and support the growth of thinning hair in men and women with self-perceived hair thinning.
What is the current status of trial NCT06362941?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2024-05-20. Estimated completion is 2025-02-18.
What interventions are being tested in trial NCT06362941?
The interventions under investigation include: Nutrafol Women's Hair Growth Supplemnt (DIETARY_SUPPLEMENT), Nutrafol Women's Balance Hair Growth Supplement (DIETARY_SUPPLEMENT), Nutrafol Women's Vegan Hair Growth Supplement (DIETARY_SUPPLEMENT), Nutrafol Women's Postpartum Hair Growth Supplement (DIETARY_SUPPLEMENT), Nutrafol Men's Hair Growth Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06362941?
This trial is sponsored by Nutraceutical Wellness, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06362941's enrollment target sits among peer trials
250 410th of 2000 higher than 1,567 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI